EarningsQ3 2025 Earnings Report

Nektar Therapeutics (NKTR) Q3 2025 Earnings Report

0 Followers

MX:NKTR Q3 2025 EPS Results

Actual EPS-$33.80

Consensus EPS-$48.53

Beat/MissBeat by +$14.73

One Year Ago EPS-$48.80

Actual Revenue$213.09M

Expected Revenue$181.71M

Beat/MissBeat by +$31.38M

YoY Revenue Growth-51.13%

QuarterQ3 2025

Date11/06/2025

TimeAfter Close

Conference CallThursday, November 6, 2025

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q3 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.94 / -	-33.797	―
Aug 13, 2026	2026 (Q2)	-35.62 / -22.23	-53.316	58.31% (+31.09)
May 07, 2026	2026 (Q1)	-28.59 / -32.89	-65.064	49.44% (+32.17)
Mar 12, 2026	2025 (Q4)	-44.71 / -32.17	8.133	-495.56% (-40.30)
Nov 06, 2025	2025 (Q3)	-48.53 / -33.80	-48.798	30.74% (+15.00)
Aug 07, 2025	2025 (Q2)	-54.73 / -53.32	-67.775	21.33% (+14.46)
May 08, 2025	2025 (Q1)	-46.34 / -65.06	-51.509	-26.32% (-13.56)
Mar 12, 2025	2024 (Q4)	-36.76 / 8.13	-59.642	113.64% (+67.78)
Nov 07, 2024	2024 (Q3)	-53.95 / -48.80	-65.064	25.00% (+16.27)
Aug 08, 2024	2024 (Q2)	-50.15 / -67.78	-73.197	7.41% (+5.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed